CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...

(Reuters) - Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly ...

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...

This was the stock's second consecutive day of gains.

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their ...

Anger at the company, and the health insurance industry more broadly, boiled over last month following the murder of ...

The stock's fall snapped a four-day winning streak.

The slain CEO of the insurer had a vision for positive change; his company should embrace new consumer remedies, writes .

Shareholders of UnitedHealth Group (UHG) are calling on the company’s board of directors to release a report on how its ...

UnitedHealth Group Inc. is set to report financial results Thursday, the first time its executives will speak publicly since ...